NCT07415031 2026-04-08
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Mirati Therapeutics Inc.
Phase 2 Not yet recruiting
Mirati Therapeutics Inc.
Fudan University
Multitude Therapeutics Inc.
Gruppo Oncologico Italia Meridionale
Shanghai Zhongshan Hospital
Fujian Cancer Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Liaoning Cancer Hospital & Institute